- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biostem Technologies Inc (BSEM)
Biostem Technologies Inc stock price live, this page displays NASDAQ BSEM stock exchange data. View the BSEM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biostem Technologies Inc real time stock price chart below.
What Is the Biostem Technologies Inc Stock Price Today?
The Biostem Technologies Inc stock price today is 3.8000.
What Is the Stock Symbol for Biostem Technologies Inc?
The stock symbol for Biostem Technologies Inc is "BSEM."
What Stock Exchange Does Biostem Technologies Inc Trade On?
Biostem Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Biostem Technologies Inc a Good Stock to Buy?
Determining whether Biostem Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSEM quote. (ISIN: US0906842002)
What Is the Biostem Technologies Inc Stock Price Today?
The Biostem Technologies Inc stock price today is 3.8000.
What Is the Stock Symbol for Biostem Technologies Inc?
The stock symbol for Biostem Technologies Inc is "BSEM."
What Stock Exchange Does Biostem Technologies Inc Trade On?
Biostem Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Biostem Technologies Inc a Good Stock to Buy?
Determining whether Biostem Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSEM quote. (ISIN: US0906842002)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.5500
4.1500
52 wk Range
3.0100
10.6500
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.55004.1500
52 wk Range
3.010010.6500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BSEM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
7.0000
Upside
+84.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Form 8K Biostem Technologies Inc For: 12 August- Investing.com
- Form 8K Biostem Technologies Inc For: 12 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.0000
(+84.21% Upside)
Biostem Technologies Inc Earnings Call Summary for Q2/2026
- BioStem posted Q2 2026 loss of $0.52/share on $7.9M revenue, missing estimates of $0.08 loss on $11M revenue; shares rose 10.8% on raised guidance.
- Company raised FY 2026 revenue guidance to $26M-$29M from $25M-$29M, citing hospital-channel growth which now represents 85% of business.
- Sequential revenue grew 29.5% from Q1's $6.1M; gross margin held at 61%, expected to reach 70%+ after in-house manufacturing transition in H1 2027.
- Cash declined to $7.0M from $13.7M with $5.5M quarterly burn; firm evaluating non-dilutive financing for $10M contingent payment liability.
- Management expects flat operating expenses through 2026, first 510(k) clearance this year, and continued hospital sales expansion to 40+ reps by year-end.
Last Updated: 2026-08-12, 05:16 p/m
Read Full TranscriptEarnings
Latest Release
Aug 12, 2026
EPS / Forecast
-0.52 / -0.08
Revenue / Forecast
7.9M / 11M
Compare BSEM to Peers and Sector
Metrics to compare | BSEM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBSEMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.5x | −1.1x | −0.3x | |
PEG Ratio | 0.02 | 0.06 | 0.00 | |
Price/Book | 2.1x | 0.4x | 2.6x | |
Price / LTM Sales | 1.8x | 3.2x | 3.1x | |
Upside (Analyst Target) | 84.2% | 32.9% | 48.3% | |
Fair Value Upside | Unlock | 8.8% | 6.7% | Unlock |
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Biostem Tech (BSEM) Stock Price Today?
The Biostem Tech stock price today is 3.8000 USD.
What Stock Exchange Does Biostem Tech Trade On?
Biostem Tech is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Biostem Tech?
The stock symbol for Biostem Tech is "BSEM."
What Is the Biostem Tech Market Cap?
As of today, Biostem Tech market cap is 67.3600M USD.
What Is Biostem Tech's Earnings Per Share (TTM)?
The Biostem Tech EPS (TTM) is -1.1512.
When Is the Next Biostem Tech Earnings Date?
Biostem Tech will release its next earnings report on Nov 17, 2026.
From a Technical Analysis Perspective, Is BSEM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Biostem Tech Stock Split?
Biostem Tech has split 5 times.
How Many Employees Does Biostem Tech Have?
Biostem Tech has 73 employees.
What is the current trading status of Biostem Tech (BSEM)?
As of Aug 13, 2026, Biostem Tech (BSEM) is trading at a price of 3.8000 USD, with a previous close of 3.8000 USD. The stock has fluctuated within a day range of 3.5500 USD to 4.1500 USD, while its 52-week range spans from 3.0100 USD to 10.6500 USD.
What Is Biostem Tech (BSEM) Price Target According to Analysts?
The average 12-month price target for Biostem Tech is 7.0000 USD, with a high estimate of 7 USD and a low estimate of 7 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +84.21% Upside potential.
What Is the BSEM Premarket Price?
BSEM's last pre-market stock price is 3.8500 USD. The pre-market share volume is 610.0000, and the stock has decreased by 0.0500, or 1.3200%.
What Is the BSEM After Hours Price?
BSEM's last after hours stock price is 3.8500 USD, the stock has decreased by 0.0500, or 1.3200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.